Identification of a Locus Near ULK1 Associated With Progression-Free Survival in Ovarian Cancer

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Identification of a Locus Near ULK1 Associated With Progression-Free Survival in Ovarian Cancer. / Quinn, Michael C. J.; McCue, Karen; Shi, Wei; Johnatty, Sharon E.; Beesley, Jonathan; Civitarese, Andrew; O'Mara, Tracy A.; Glubb, Dylan M.; Tyrer, Jonathan P.; Armasu, Sebastian M.; Ong, Jue-Sheng; Gharahkhani, Puya; Gao, Bo; Patch, Ann-Marie; Fasching, Peter A.; Beckmann, Matthias W.; Lambrechts, Diether; Vergote, Ignace; Edwards, Digna R. Velez; Beeghly-Fadiel, Alicia; Benitez, Javier; Garcia, Maria J.; Goodman, Marc T.; Doerk, Thilo; Duerst, Matthias; Modugno, Francesmary; Moysich, Kirsten; du Bois, Andreas; Pfisterer, Jacobus; Bauman, Klaus; Karlan, Beth Y.; Lester, Jenny; Cunningham, Julie M.; Larson, Melissa C.; McCauley, Bryan M.; Kjaer, Susanne K.; Jensen, Allan; Hogdall, Claus K.; Hogdall, Estrid; Schildkraut, Joellen M.; Riggan, Marjorie J.; Berchuck, Andrew; Cramer, Daniel W.; Terry, Kathryn L.; Bjorge, Line; Webb, Penelope M.; Friedlander, Michael; Pejovic, Tanja; Moffitt, Melissa; Glasspool, Rosalind.

I: Cancer Epidemiology, Biomarkers & Prevention, Bind 30, Nr. 9, 09.2021, s. 1669-1680.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Quinn, MCJ, McCue, K, Shi, W, Johnatty, SE, Beesley, J, Civitarese, A, O'Mara, TA, Glubb, DM, Tyrer, JP, Armasu, SM, Ong, J-S, Gharahkhani, P, Gao, B, Patch, A-M, Fasching, PA, Beckmann, MW, Lambrechts, D, Vergote, I, Edwards, DRV, Beeghly-Fadiel, A, Benitez, J, Garcia, MJ, Goodman, MT, Doerk, T, Duerst, M, Modugno, F, Moysich, K, du Bois, A, Pfisterer, J, Bauman, K, Karlan, BY, Lester, J, Cunningham, JM, Larson, MC, McCauley, BM, Kjaer, SK, Jensen, A, Hogdall, CK, Hogdall, E, Schildkraut, JM, Riggan, MJ, Berchuck, A, Cramer, DW, Terry, KL, Bjorge, L, Webb, PM, Friedlander, M, Pejovic, T, Moffitt, M & Glasspool, R 2021, 'Identification of a Locus Near ULK1 Associated With Progression-Free Survival in Ovarian Cancer', Cancer Epidemiology, Biomarkers & Prevention, bind 30, nr. 9, s. 1669-1680. https://doi.org/10.1158/1055-9965.EPI-20-1817

APA

Quinn, M. C. J., McCue, K., Shi, W., Johnatty, S. E., Beesley, J., Civitarese, A., O'Mara, T. A., Glubb, D. M., Tyrer, J. P., Armasu, S. M., Ong, J-S., Gharahkhani, P., Gao, B., Patch, A-M., Fasching, P. A., Beckmann, M. W., Lambrechts, D., Vergote, I., Edwards, D. R. V., ... Glasspool, R. (2021). Identification of a Locus Near ULK1 Associated With Progression-Free Survival in Ovarian Cancer. Cancer Epidemiology, Biomarkers & Prevention, 30(9), 1669-1680. https://doi.org/10.1158/1055-9965.EPI-20-1817

Vancouver

Quinn MCJ, McCue K, Shi W, Johnatty SE, Beesley J, Civitarese A o.a. Identification of a Locus Near ULK1 Associated With Progression-Free Survival in Ovarian Cancer. Cancer Epidemiology, Biomarkers & Prevention. 2021 sep.;30(9):1669-1680. https://doi.org/10.1158/1055-9965.EPI-20-1817

Author

Quinn, Michael C. J. ; McCue, Karen ; Shi, Wei ; Johnatty, Sharon E. ; Beesley, Jonathan ; Civitarese, Andrew ; O'Mara, Tracy A. ; Glubb, Dylan M. ; Tyrer, Jonathan P. ; Armasu, Sebastian M. ; Ong, Jue-Sheng ; Gharahkhani, Puya ; Gao, Bo ; Patch, Ann-Marie ; Fasching, Peter A. ; Beckmann, Matthias W. ; Lambrechts, Diether ; Vergote, Ignace ; Edwards, Digna R. Velez ; Beeghly-Fadiel, Alicia ; Benitez, Javier ; Garcia, Maria J. ; Goodman, Marc T. ; Doerk, Thilo ; Duerst, Matthias ; Modugno, Francesmary ; Moysich, Kirsten ; du Bois, Andreas ; Pfisterer, Jacobus ; Bauman, Klaus ; Karlan, Beth Y. ; Lester, Jenny ; Cunningham, Julie M. ; Larson, Melissa C. ; McCauley, Bryan M. ; Kjaer, Susanne K. ; Jensen, Allan ; Hogdall, Claus K. ; Hogdall, Estrid ; Schildkraut, Joellen M. ; Riggan, Marjorie J. ; Berchuck, Andrew ; Cramer, Daniel W. ; Terry, Kathryn L. ; Bjorge, Line ; Webb, Penelope M. ; Friedlander, Michael ; Pejovic, Tanja ; Moffitt, Melissa ; Glasspool, Rosalind. / Identification of a Locus Near ULK1 Associated With Progression-Free Survival in Ovarian Cancer. I: Cancer Epidemiology, Biomarkers & Prevention. 2021 ; Bind 30, Nr. 9. s. 1669-1680.

Bibtex

@article{76ca63258e7748a99d0d52a91b137322,
title = "Identification of a Locus Near ULK1 Associated With Progression-Free Survival in Ovarian Cancer",
abstract = "Background: Many loci have been found to be associated with risk of epithelial ovarian cancer (EOC). However, although there is considerable variation in progression-free survival (PFS), no loci have been found to be associated with outcome at genome-wide levels of significance.Methods: We carried out a genome-wide association study (GWAS) of PFS in 2,352 women with EOC who had undergone cytoreductive surgery and standard carboplatin/paclitaxel chemotherapy.Results: We found seven SNPs at 12q24.33 associated with PFS (P < 5 x 10(-8)), the top SNP being rs10794418 (HR = 1.24; 95% CI, 1.15-1.34; P = 1.47 x 10(-8)). High expression of a nearby gene, ULK1, is associated with shorter PFS in EOC, and with poor prognosis in other cancers. SNP rs10794418 is also associated with expression of ULK1 in ovarian tumors, with the allele associated with shorter PFS being associated with higher expression, and chromatin interactions were detected between the ULK1 promoter and associated SNPs in serous and endometrioid EOC cell lines. ULK1 knockout ovarian cancer cell lines showed significantly increased sensitivity to carboplatin in vitro.Conclusions: The locus at 12q24.33 represents one of the first genome-wide significant loci for survival for any cancer. ULK1 is a plausible candidate for the target of this association.Impact: This finding provides insight into genetic markers associated with EOC outcome and potential treatment options.",
keywords = "SEROUS OVARIAN, SUSCEPTIBILITY LOCI, AUTOPHAGY, POLYMORPHISMS, OUTCOMES, KINASE, METAANALYSIS, CONSORTIUM, EXPRESSION, LIKELIHOOD",
author = "Quinn, {Michael C. J.} and Karen McCue and Wei Shi and Johnatty, {Sharon E.} and Jonathan Beesley and Andrew Civitarese and O'Mara, {Tracy A.} and Glubb, {Dylan M.} and Tyrer, {Jonathan P.} and Armasu, {Sebastian M.} and Jue-Sheng Ong and Puya Gharahkhani and Bo Gao and Ann-Marie Patch and Fasching, {Peter A.} and Beckmann, {Matthias W.} and Diether Lambrechts and Ignace Vergote and Edwards, {Digna R. Velez} and Alicia Beeghly-Fadiel and Javier Benitez and Garcia, {Maria J.} and Goodman, {Marc T.} and Thilo Doerk and Matthias Duerst and Francesmary Modugno and Kirsten Moysich and {du Bois}, Andreas and Jacobus Pfisterer and Klaus Bauman and Karlan, {Beth Y.} and Jenny Lester and Cunningham, {Julie M.} and Larson, {Melissa C.} and McCauley, {Bryan M.} and Kjaer, {Susanne K.} and Allan Jensen and Hogdall, {Claus K.} and Estrid Hogdall and Schildkraut, {Joellen M.} and Riggan, {Marjorie J.} and Andrew Berchuck and Cramer, {Daniel W.} and Terry, {Kathryn L.} and Line Bjorge and Webb, {Penelope M.} and Michael Friedlander and Tanja Pejovic and Melissa Moffitt and Rosalind Glasspool",
year = "2021",
month = sep,
doi = "10.1158/1055-9965.EPI-20-1817",
language = "English",
volume = "30",
pages = "1669--1680",
journal = "Cancer Epidemiology, Biomarkers & Prevention",
issn = "1055-9965",
publisher = "American Association for Cancer Research (A A C R)",
number = "9",

}

RIS

TY - JOUR

T1 - Identification of a Locus Near ULK1 Associated With Progression-Free Survival in Ovarian Cancer

AU - Quinn, Michael C. J.

AU - McCue, Karen

AU - Shi, Wei

AU - Johnatty, Sharon E.

AU - Beesley, Jonathan

AU - Civitarese, Andrew

AU - O'Mara, Tracy A.

AU - Glubb, Dylan M.

AU - Tyrer, Jonathan P.

AU - Armasu, Sebastian M.

AU - Ong, Jue-Sheng

AU - Gharahkhani, Puya

AU - Gao, Bo

AU - Patch, Ann-Marie

AU - Fasching, Peter A.

AU - Beckmann, Matthias W.

AU - Lambrechts, Diether

AU - Vergote, Ignace

AU - Edwards, Digna R. Velez

AU - Beeghly-Fadiel, Alicia

AU - Benitez, Javier

AU - Garcia, Maria J.

AU - Goodman, Marc T.

AU - Doerk, Thilo

AU - Duerst, Matthias

AU - Modugno, Francesmary

AU - Moysich, Kirsten

AU - du Bois, Andreas

AU - Pfisterer, Jacobus

AU - Bauman, Klaus

AU - Karlan, Beth Y.

AU - Lester, Jenny

AU - Cunningham, Julie M.

AU - Larson, Melissa C.

AU - McCauley, Bryan M.

AU - Kjaer, Susanne K.

AU - Jensen, Allan

AU - Hogdall, Claus K.

AU - Hogdall, Estrid

AU - Schildkraut, Joellen M.

AU - Riggan, Marjorie J.

AU - Berchuck, Andrew

AU - Cramer, Daniel W.

AU - Terry, Kathryn L.

AU - Bjorge, Line

AU - Webb, Penelope M.

AU - Friedlander, Michael

AU - Pejovic, Tanja

AU - Moffitt, Melissa

AU - Glasspool, Rosalind

PY - 2021/9

Y1 - 2021/9

N2 - Background: Many loci have been found to be associated with risk of epithelial ovarian cancer (EOC). However, although there is considerable variation in progression-free survival (PFS), no loci have been found to be associated with outcome at genome-wide levels of significance.Methods: We carried out a genome-wide association study (GWAS) of PFS in 2,352 women with EOC who had undergone cytoreductive surgery and standard carboplatin/paclitaxel chemotherapy.Results: We found seven SNPs at 12q24.33 associated with PFS (P < 5 x 10(-8)), the top SNP being rs10794418 (HR = 1.24; 95% CI, 1.15-1.34; P = 1.47 x 10(-8)). High expression of a nearby gene, ULK1, is associated with shorter PFS in EOC, and with poor prognosis in other cancers. SNP rs10794418 is also associated with expression of ULK1 in ovarian tumors, with the allele associated with shorter PFS being associated with higher expression, and chromatin interactions were detected between the ULK1 promoter and associated SNPs in serous and endometrioid EOC cell lines. ULK1 knockout ovarian cancer cell lines showed significantly increased sensitivity to carboplatin in vitro.Conclusions: The locus at 12q24.33 represents one of the first genome-wide significant loci for survival for any cancer. ULK1 is a plausible candidate for the target of this association.Impact: This finding provides insight into genetic markers associated with EOC outcome and potential treatment options.

AB - Background: Many loci have been found to be associated with risk of epithelial ovarian cancer (EOC). However, although there is considerable variation in progression-free survival (PFS), no loci have been found to be associated with outcome at genome-wide levels of significance.Methods: We carried out a genome-wide association study (GWAS) of PFS in 2,352 women with EOC who had undergone cytoreductive surgery and standard carboplatin/paclitaxel chemotherapy.Results: We found seven SNPs at 12q24.33 associated with PFS (P < 5 x 10(-8)), the top SNP being rs10794418 (HR = 1.24; 95% CI, 1.15-1.34; P = 1.47 x 10(-8)). High expression of a nearby gene, ULK1, is associated with shorter PFS in EOC, and with poor prognosis in other cancers. SNP rs10794418 is also associated with expression of ULK1 in ovarian tumors, with the allele associated with shorter PFS being associated with higher expression, and chromatin interactions were detected between the ULK1 promoter and associated SNPs in serous and endometrioid EOC cell lines. ULK1 knockout ovarian cancer cell lines showed significantly increased sensitivity to carboplatin in vitro.Conclusions: The locus at 12q24.33 represents one of the first genome-wide significant loci for survival for any cancer. ULK1 is a plausible candidate for the target of this association.Impact: This finding provides insight into genetic markers associated with EOC outcome and potential treatment options.

KW - SEROUS OVARIAN

KW - SUSCEPTIBILITY LOCI

KW - AUTOPHAGY

KW - POLYMORPHISMS

KW - OUTCOMES

KW - KINASE

KW - METAANALYSIS

KW - CONSORTIUM

KW - EXPRESSION

KW - LIKELIHOOD

U2 - 10.1158/1055-9965.EPI-20-1817

DO - 10.1158/1055-9965.EPI-20-1817

M3 - Journal article

C2 - 34162658

VL - 30

SP - 1669

EP - 1680

JO - Cancer Epidemiology, Biomarkers & Prevention

JF - Cancer Epidemiology, Biomarkers & Prevention

SN - 1055-9965

IS - 9

ER -

ID: 286634664